Cancer IOs new PBS phantoms

By Megan Brodie 3 years ago | In Products, Regulatory
  • 3 years ago
Phantom spending on the PBS continues to inflate the actual cost of the scheme.

16 August 2021 The checkpoint inhibitor class of immuno-oncology blockbusters has moved up to replace…

This is subscriber-only content. Please login to continue reading.